OMX30 1 567 -0,2%  OMXH25 3 719 0,2%  OMXC20 912 0,0%  Dow 20 822 0,1%  Nas 5 343 0,2%  EUR 9,5520 0,1%  USD 9,0240 -0,1%  Olja 56,7 1,2%  Guld 1 256 -0,1% 

Johnson & Johnson Aktie

122,72USD 1,12USD 0,92%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Johnson & Johnson

2016 2017e 2018e 2019e 2020e
Utdelning 3,15 3,35 3,55 3,77 3,86
Direktavkastning (i %) 2,71 2,77 2,94 3,12 3,20
PE-tal 17,24 17,11 16,23 15,31 14,38
Resultat/aktie 6,73 7,05 7,43 7,88 8,38
ytterligare nyheter

Analyser om Johnson & Johnson

Jun, 13 2016 Johnson & Johnson Neutral Goldman Sachs Group Inc.
ytterligare analyser

Johnson & Johnson Peer Group

Abbott Laboratories 45,67
0,6%
Alexion Pharmaceuticals 131,49
0,8%
AstraZeneca 525,50
0,0%
Bayer 104,65
0,4%
Beiersdorf 86,81
0,3%
Celgene 118,26
-0,8%
Fresenius Medical Care 77,86
0,3%
Fresenius 75,32
-0,5%
GlaxoSmithKline 16,44
0,2%
Johnson & Johnson 122,72
0,9%
Merck 66,13
0,4%
Merck 103,15
0,0%
MorphoSys 52,67
1,5%
Nestle SA 74,30
-0,3%
Novartis 77,65
0,1%
Pfizer 34,25
0,7%
Procter & Gamble 91,04
-0,1%
Roche 247,20
-0,5%
STADA Arzneimittel 57,59
0,2%
Sanofi 80,62
0,0%
Unilever 44,89
0,9%
pagehit

Lägg till instrument

Vad tycker du?

Profil Johnson & Johnson

till bolagsprofilen
Johnson & Johnson is an investment holding company with interests in health care products. It engages in research and development, manufacture and sale of personal care hygienic products, pharmaceuticals and surgical equipment. The company operates through the following business segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes products used in the baby care, skin care, oral care, wound care and women's health care fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms. The baby care franchise includes the JOHNSON'S Baby line of products. The Pharmaceutical segment includes products in the anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis and vaccines. The Medical Devices segment includes products distributed to wholesalers, hospitals and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. These include products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. Johnson & Johnson was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Realtidskurs Johnson & Johnson

Bid
112,00
USD
Ask
122,71
USD
Kurstid
21:59
Börsen BTT

Aktiekurs Johnson & Johnson i USDPUSH CHART

Kurs 122,72 USD 1,12 0,92 %
Kurstid 21:59:58
Datum 24.02.2017
Öppning 121,20
Gårdagen 122,72
Dagshögsta 122,73
Dagslägsta 121,20
52 v. högsta 126,25
52 v. lägsta 104,78
52 v. perf.
Volym (Antal) 728 005
Börsvärde (SEK) 3 002,83 Mrd
Börsen
Kurs för 122,72 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 1 107,38 SEK.

Till aktien Johnson & Johnson

Ticker
ISIN US4781601046
Index BX Swiss - USA, Dow Jones, S&P 500, S&P 100, NYSE US 100

Struktuerarde produkter på Johnson & Johnson

Produkttyp Antal
Plain Vanilla Warrants 1
Certificates 2

Johnson & Johnson Nyckeltal

Börsvärde i SEK 3 002,83 Mrd
Free float % 99,90
Antal aktier mio. 2 720,53
Cashflow/aktie i lokal valuta 6,47
Bokvärde/aktie i lokal valuta 27,40
60 dagar vola 14,58
PBV 4,24

Johnson & Johnson Historiska kurser

2017-02-24 122,72 728 005
2017-02-23 121,60 522 302
2017-02-22 119,50 234 395
2017-02-21 119,64 458 361
2017-02-17 118,84 401 525

Aktier i samma industri med bättre 1 års perf.

SIGA Technologies Inc. 483,4 %
Exelixis Inc. 476,2 %
Ariad Pharmaceuticals Inc. 382,2 %
Array BioPharma Inc. 314,8 %
Amylin Pharmaceuticals Inc. 264,9 %